TruBridge Earnings Call Transcripts
Fiscal Year 2026
-
Stockholders approved the merger to become a subsidiary of IKS and gave advisory approval to executive compensation related to the merger. No questions were raised, and both proposals passed by majority vote.
Fiscal Year 2025
-
Revenue and Adjusted EBITDA grew year-over-year, with margin expansion driven by cost optimization and a strong pipeline of recurring, higher-margin deals. Strategic review is ongoing, with no formal guidance, but modest revenue growth and further margin gains are expected in 2026.
-
Q3 2025 saw revenue rise 2% year-over-year to $86.1M, with adjusted EBITDA margin up to 18.9%. Bookings were below expectations but of higher quality, and cost optimization plus offshore transitions are set to drive further margin expansion into 2026.
-
Q2 2025 saw strong bookings, improved margins, and robust cash flow, though revenue guidance was lowered due to client retention and delayed deal implementations. Operational efficiencies, offshoring, and AI innovation are driving profitability, with retention stabilizing and new deals set to contribute in 2026.
-
Focused on rural hospitals, the business is driving growth through technology innovation, SaaS transitions, and RCM services. Financial performance is strong, with improved margins and reduced leverage, while leadership emphasizes disciplined acquisitions and customer-centric strategies.
-
Q1 2025 saw strong financial performance with revenue and adjusted EBITDA at the high end of guidance, improved margins, and reduced leverage. Bookings and customer retention were robust, with continued progress in workforce optimization and SaaS adoption.
-
The company has unified its brand, improved margins, and reduced leverage while focusing on growth in rural healthcare through RCM expansion, operational efficiencies, and strategic acquisitions. With a stable market, SaaS transition, and enhanced forecasting, it targets significant long-term growth.
Fiscal Year 2024
-
Q4 and full-year results exceeded guidance, with revenue and EBITDA growth driven by operational improvements, cost rationalization, and the Viewgol acquisition. 2025 guidance calls for 4% revenue growth and further margin expansion, led by financial health segment strength.
-
Labor shortages and regulatory changes are fueling demand for outsourced RCM and EHR solutions, with bookings and recurring revenue at record levels. Operational transformation through offshoring and automation is expected to drive margin expansion and cash flow improvements, while disciplined capital allocation and attrition management support sustainable growth.
-
Bookings exceeded $20 million for the fourth straight quarter, with strong organic growth in Financial Health and expanding margins. Guidance for 2024 was raised to the high end, and 2025 targets further margin improvement and mid- to high-single-digit revenue growth.
-
Q2 2024 delivered strong bookings, improved margins, and positive cash flow, with integrated solutions and offshoring initiatives driving operational gains. Guidance for 2024 is reiterated, with continued focus on margin expansion, debt reduction, and cross-segment growth.
-
TruBridge has rebranded and sharpened its focus on rural healthcare, with RCM now driving most revenue. Margin expansion is expected from offshoring, cost actions, and the Viewgol acquisition, while a new analytics platform and EHR consolidation aim to boost growth and efficiency. TruBridge is prioritizing debt reduction and operational improvements.